Glenmark Pharmaceuticals Limited (GLENMARK) Share Price & AI Investment Analysis

Glenmark Pharmaceuticals Limited, together with its subsidiaries, research, develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally. The company provides various products in the therapeutic areas of dermatology, respiratory, oncology, cardiology, diabetes, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injectables and biologics, oral solids, liquids, topical products, and respiratory-metered dose inhaler, dry powder inhaler, and nasal sprays. Its pro. Track Glenmark Pharmaceuticals Limited's live NSE:GLENMARK share price ₹2,461.40 (+0.47%), market cap ₹₹695B, P/E 38.6. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for GLENMARK — real-time NSE India stock intelligence.